{
  "image_filename": "table_p6_det_5_006.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p6_det_5_006.png",
  "image_type": "Table",
  "page_number": 6,
  "block_id": "det_5_006",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "A three-column table listing influenza vaccine types (Egg-based IIV4s, ccIIV4, RIV4, LAIV4) with their respective contraindications and precautions. does not support the claim \u2013 the table only details contraindications and precautions for various vaccine types and contains no data on immune response breadth, cross-protection, or mismatch season performance. Note: The image quality is sufficient but the table does not include any immunogenicity or cross-protection information.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A three-column table listing influenza vaccine types (Egg-based IIV4s, ccIIV4, RIV4, LAIV4) with their respective contraindications and precautions.",
    "evidence_found": null,
    "reasoning": "does not support the claim \u2013 the table only details contraindications and precautions for various vaccine types and contains no data on immune response breadth, cross-protection, or mismatch season performance.",
    "confidence_notes": "The image quality is sufficient but the table does not include any immunogenicity or cross-protection information."
  }
}